Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy (Q73145757)
Jump to navigation
Jump to search
scientific article published on 01 January 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy |
scientific article published on 01 January 1999 |
Statements
Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy (English)
L O Hattenbach
A Allers
H O Gümbel
I Scharrer
1 January 1999